Group | Food Consumption | Body Weight Gain | Leukocytes | TNF |
---|---|---|---|---|
g | % | cells/mm3 | pg/ml | |
Control | 25.7 ± 1.8 | 30.7 ± 2.3 | 11,379 ± 1,590 | <4 |
LA-419 | 26.2 ± 1.4 | 28.7 ± 2.2 | 12,675 ± 1,921 | <4 |
INDO (active) | 25.1 ± 1.9 | 12.2 ± 2.1 | 18,058 ± 822.9 | 56.1 ± 10.8 |
INDO (inactive) | 14,204 ± 1,154 | 32.1 ± 8.8 | ||
INDO + LA-419 (preventive treatment) | 25.3 ± 1.7 | 20.2 ± 2.3** | 13,283 ± 1,089++ | 10.9 ± 9.7+ |
INDO + LA-419 (therapeutic treatment) | 26.3 ± 1.7 | 12.7 ± 2.3 | 16,213 ± 1,236+ | 27.8 ± 10.6 |